1 – 10 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
Malmros, Karina LU ; Lindholm, Andreas ; Vidarsdottir, Halla LU ; Jirström, Karin LU
; Nodin, Björn
LU
; Botling, Johan
; Mattsson, Johanna S.M.
; Micke, Patrick
; Planck, Maria
LU
and Jönsson, Mats
LU
, et al.
(2024)
In Virchows Archiv
485.
p.347-357
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
Nobin, Hampus LU ; Garvin, Stina ; Hagman, Helga LU
; Nodin, Björn
LU
; Jirström, Karin
LU
and Brunnström, Hans
LU
(2024)
In BMC Cancer
24.
p.1-16
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
Huss, Linnea LU ; Gulz-Haake, Igis LU ; Nilsson, Emma LU ; Tryggvadottir, Helga LU ; Nilsson, Linn LU ; Nodin, Björn LU ; Jirström, Karin LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
(2024)
In Nutrients
16(7).
p.1-15
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher LU
; Khazaei, Somayeh
LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Nodin, Björn
LU
; Jirström, Karin
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In PLoS ONE
19(7).
p.1-21
- Contribution to journal › Article
- 2023
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
- Contribution to journal › Article
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
Dahlgren, Malin LU ; Lettiero, Barbara LU ; Dalal, Hina LU
; Mårtensson, Kira
; Gaber, Alexander
LU
; Nodin, Björn
LU
; Gruvberger, Sofia
LU
; Saal, Lao H
LU
and Howlin, Jillian
LU
(2023)
In BMC Research Notes
16(1).
- Contribution to journal › Article
- 2022
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
Petersson, Alexandra LU ; Andersson, Natalie LU
; Olsson Hau, Sofie
LU
; Eberhard, Jakob
LU
; Karlsson, Jenny
LU
; Chattopadhyay, Subhayan
LU
; Valind, Anders
LU
; Elebro, Jacob
LU
; Nodin, Björn
LU
and Leandersson, Karin
LU
, et al.
(2022)
In Molecular Cancer Research
20(5).
p.749-761
- Contribution to journal › Article
-
Mark
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer : longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
Wahlin, Sara LU ; Boman, Karolina LU ; Moran, Bruce ; Nodin, Björn LU ; Gallagher, William M. ; Karnevi, Emelie LU and Jirström, Karin LU
(2022)
In BMC Cancer
22(1).
- Contribution to journal › Article
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
Siesing, Christina LU ; Petersson, Alexandra LU ; Ulfarsdottir, Thora ; Chattopadhyay, Subhayan LU
; Nodin, Björn
LU
; Eberhard, Jakob
LU
; Brändstedt, Jenny
LU
; Syk, Ingvar
LU
; Gisselsson Nord, David
LU
and Jirström, Karin
LU
(2022)
In Modern Pathology
35(7).
p.979-988
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
Godina, Christopher LU
; Indira Chandran, Vineesh
LU
; Barbachowska, Magdalena
LU
; Tryggvadottir, Helga
LU
; Nodin, Björn
LU
; Visse, Edward
LU
; Borgquist, Signe
LU
; Jirström, Karin
LU
; Isaksson, Karolin
LU
and Bosch, Ana
LU
, et al.
(2022)
In Translational Oncology
22.
- Contribution to journal › Article